<sup>131</sup>Ⅰ治疗Graves病后远期并发甲减的再随访

邓守真; 林祥通; 何婉婷; 张凯莉; 张锦明; 蒯大禹

您当前的位置：

首页 >

文章列表页 >

¹³¹Ⅰ治疗Graves病后远期并发甲减的再随访

更新时间：2021-04-20

- ¹³¹Ⅰ治疗Graves病后远期并发甲减的再随访
- Hypothyroidism caused by ¹³¹I treatment for Graves disease --A refollow-up
- 核技术 1991年第5期
- 作者机构：
  
  上海医科大学华山医院
- 作者简介：
- 基金信息：
- DOI：
  中图分类号：
- 纸质出版日期：1991-05-01
- 稿件说明：
移动端阅览
[1]邓守真,林祥通,何婉婷,张凯莉,张锦明,蒯大禹.~(131)Ⅰ治疗Graves病后远期并发甲减的再随访[J].核技术,1991(05):269-272.

Deng Shouzhen Lin Xiangtong He Wanting Zhang KailiZhang Jinming Kuai Dayu. Hypothyroidism caused by ¹³¹I treatment for Graves disease --A refollow-up[J]. Nuclear techniques, 1991, (5): 269-272.
[1]邓守真,林祥通,何婉婷,张凯莉,张锦明,蒯大禹.~(131)Ⅰ治疗Graves病后远期并发甲减的再随访[J].核技术,1991(05):269-272. DOI：

Deng Shouzhen Lin Xiangtong He Wanting Zhang KailiZhang Jinming Kuai Dayu. Hypothyroidism caused by ¹³¹I treatment for Graves disease --A refollow-up[J]. Nuclear techniques, 1991, (5): 269-272. DOI：

摘要

作者在1985年对

131

I治疗Graves病后远期并发甲减随访的基础上

采用HS-TSH（IRMA）、FT

、TSH、TT

、TT

、FT

I、TRH兴奋试验及MCA、TGA、胆固醇、甘油三脂等项目测定

并结合临床症状、体征对26例（治疗年限平均9.5a）患者进行随访

通过对上述指标比较

指出TSH诊断符合率最高

胆固醇、FT

I其次

甲减的并发似与患者甲状腺抗体（MCA、TGA）存在有关

并认为

131

Ⅰ治疗后患者长期随访TSH、FT

I及胆固醇

有助于及早发现并发甲减和对甲减在替代治疗中病情控制的判断。

Abstract

The refollow-up has been carried out in hypothyroidism caused by 131I treatment for Graves disease. The serum HS-TSH（IRMA）

FT3

TSH（RIA）

TT3

TT4

FT4I

MCA

TGA

Cholesterol and Triglyceride has been measured in 26 patient after 131I treatment for 9.5 yea.rs in average. At the same time TRH stimulation test was also performed

and the clinical symptoms and signs assessed. The results showed that TSH is the most sensitive criterion for hypothyroidism

followed by Cholesterol and FT4I. The occurrence of hypo-thyroidism may be related to the presence of thyroid antibody as demonstrated by the elevation of serum MCA

TGA. Therefore measurement of serum TSH

FT4I and Cholesterol during long term follow-up is beneficial for early diagnosis of hypothyroidism and evaluating the effect of subtitution treatment.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

甲状腺癌术后¹³¹Ⅰ清除残留甲状腺与用量的关系

131Ⅰ治疗Graves病后远期并发甲减的再随访

Hypothyroidism caused by 131I treatment for Graves disease --A refollow-up

DOI：

摘要

Abstract

关键词

Keywords

references

¹³¹Ⅰ治疗Graves病后远期并发甲减的再随访

Hypothyroidism caused by ¹³¹I treatment for Graves disease --A refollow-up